Judgment Entered After Rare Asbestos Renal Cancer Trial Snags Mixed Results
SAN FRANCISCO — A California judge on Dec. 20 entered judgment after a jury awarded $2.86 million in one of the first ever asbestos-related renal cancer trials. The jury found one...To view the full article, register now.
Already a subscriber? Click here to view full article